Login

Executive Interview - Paion - Wolfgang Soehngen, CEO, Paion 00:00:00

Share On Facebook Share On Twitter

Discusses the group’s strategy including partnership deals with Cosmo and Mundipharma

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Assessing Regional Office Market Trends and Strategies for 2024 | Philippe Rosio , CEO,Fonciere Inea SA.
00:10:00
"Howard Marks on Oaktree Capital's Investment Philosophy and Future Outlook: An In-Depth Discussion on Asset TV"
00:10:00
Peter Thiel: The Future Lies in Bold Innovation, Not Incremental Progress
00:10:00
Revolutionizing Surgical Technology: A CEO's Perspective on Advancements and Challenges in the Medtech Industry|Anthony Fernando, CEO, Asensus Surgical Inc .
00:10:00
Chalice Gold Mines: Advancing Tier-One Gold Exploration Projects in Australia and Canada
00:10:00
Unearthing Potential: Reviving the Prisco Copper Project in South Africa
00:10:00
"BayWa AG celebrates 90 years of dedication and innovation under the leadership of its CEO, marking a remarkable anniversary of growth and success."|Marcus Pöllinger is the Chief Executive Officer of BayWa AG
00:10:00
Corero Network Security on DDoS Cyber Defense Solutions, Provides Corporate Update and Meet New CEO | Carl Herberger, CEO, Corero Network Security PLCCNS:LSE
00:10:00
Investing In What’s Important is a series featuring EP Wealth Advisors' team, where Derek Holman, CFP®, AIF, discusses the benefits of the fee-only approach and its impact on clients, especially small business owners and executives.
00:10:00
This month we interviewed Gillian Alexandre Huart, CEO of ENGIE Energy Access, a leader in Pay-As-You-Go (PAYGo) solutions.
00:10:00
Pioneering Financial Education and Community Impact | Martin Cabrera - founder and CEO of Cabrera Capital Markets and Cabrera Capital Partners
00:10:00
In-Depth Conversation with Bob Prince, Co-CIO of Bridgewater Associates: Exploring the New Paradigm, Strategic Asset Allocation, and Combining Beta and Alpha

© 2026 Nehu